(2S,3S,4S,5R)-6-[4-[2-[2-[4-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxymethyl]triazol-1-yl]ethoxy]ethyl-methylcarbamoyl]-2-[4-[(5S)-5-ethyl-5-hydroxy-6,10-dioxo-7,18,20-trioxa-11,24-diazahexacyclo[11.11.0.02,11.04,9.015,23.017,21]tetracosa-1(24),2,4(9),13,15,17(21),22-heptaen-14-yl]phenoxy]sulfonyloxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
C56H55N7O23S — CID 176814597
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S,3S,4S,5R)-6-[4-[2-[2-[4-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxymethyl]triazol-1-yl]ethoxy]ethyl-methylcarbamoyl]-2-[4-[(5S)-5-ethyl-5-hydroxy-6,10-dioxo-7,18,20-trioxa-11,24-diazahexacyclo[11.11.0.02,11.04,9.015,23.017,21]tetracosa-1(24),2,4(9),13,15,17(21),22-heptaen-14-yl]phenoxy]sulfonyloxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
(2S,3S,4S,5R)-6-[4-[2-[2-[4-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxymethyl]triazol-1-yl]ethoxy]ethyl-methylcarbamoyl]-2-[4-[(5S)-5-ethyl-5-hydroxy-6,10-dioxo-7,18,20-trioxa-11,24-diazahexacyclo[11.11.0.02,11.04,9.015,23.017,21]tetracosa-1(24),2,4(9),13,15,17(21),22-heptaen-14-yl]phenoxy]sulfonyloxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid (PubChem CID 176814597) has the molecular formula C56H55N7O23S and a molecular weight of 1226.15 g/mol. Its IUPAC name is (2S,3S,4S,5R)-6-[4-[2-[2-[4-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxymethyl]triazol-1-yl]ethoxy]ethyl-methylcarbamoyl]-2-[4-[(5S)-5-ethyl-5-hydroxy-6,10-dioxo-7,18,20-trioxa-11,24-diazahexacyclo[11.11.0.02,11.04,9.015,23.017,21]tetracosa-1(24),2,4(9),13,15,17(21),22-heptaen-14-yl]phenoxy]sulfonyloxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid.
Molecular Properties
| Compound Name | (2S,3S,4S,5R)-6-[4-[2-[2-[4-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxymethyl]triazol-1-yl]ethoxy]ethyl-methylcarbamoyl]-2-[4-[(5S)-5-ethyl-5-hydroxy-6,10-dioxo-7,18,20-trioxa-11,24-diazahexacyclo[11.11.0.02,11.04,9.015,23.017,21]tetracosa-1(24),2,4(9),13,15,17(21),22-heptaen-14-yl]phenoxy]sulfonyloxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid |
|---|---|
| PubChem CID | 176814597 |
| Molecular Formula | C56H55N7O23S |
| Molecular Weight | 1226.15 g/mol |
| Exact Mass | 1225.31 |
| IUPAC Name | (2S,3S,4S,5R)-6-[4-[2-[2-[4-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxymethyl]triazol-1-yl]ethoxy]ethyl-methylcarbamoyl]-2-[4-[(5S)-5-ethyl-5-hydroxy-6,10-dioxo-7,18,20-trioxa-11,24-diazahexacyclo[11.11.0.02,11.04,9.015,23.017,21]tetracosa-1(24),2,4(9),13,15,17(21),22-heptaen-14-yl]phenoxy]sulfonyloxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid |
| SMILES | CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc3c(cc1c2-c1ccc(OS(=O)(=O)Oc2cc(C(=O)N(C)CCOCCn4cc(COCCOCCN5C(=O)C=CC5=O)nn4)ccc2OC2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)cc1)OCO3 |
| InChI | InChI=1S/C56H55N7O23S/c1-3-56(74)36-22-38-46-34(25-63(38)52(70)35(36)27-80-55(56)73)45(33-21-40-41(82-28-81-40)23-37(33)57-46)29-4-7-32(8-5-29)85-87(75,76)86-42-20-30(6-9-39(42)83-54-49(68)47(66)48(67)50(84-54)53(71)72)51(69)60(2)12-15-77-16-13-61-24-31(58-59-61)26-79-19-18-78-17-14-62-43(64)10-11-44(62)65/h4-11,20-24,47-50,54,66-68,74H,3,12-19,25-28H2,1-2H3,(H,71,72)/t47-,48-,49+,50-,54?,56-/m0/s1 |
| InChIKey | MYJHUVVKDQFMOC-SPVSNVKYSA-N |
| XLogP | 0.29 |
| TPSA | 385.02 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 27 |
| Rotatable Bonds | 24 |
| Heavy Atoms | 87 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1226.15 |
| LogP ≤ 5 | 0.29 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 27 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 176814597 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.